Iol Chemicals And Pharmaceuticals Q2 FY27: revenue up 40.1% to ₹795 Cr, net profit up 117.1% to ₹65 Cr
Results · Finvezto · 2 Nov 2026 · Iol Chemicals And Pharmaceuticals (IOLCP)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 795 | - | +40.1% |
| Operating profit | 109 | - | +91.7% |
| Net profit | 65 | - | +117.1% |
| Operating margin | 13.8% | - | +3.7 pp |
| Net margin | 8.2% | - | +2.9 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Revenue from operations in Q2 FY27 rose approximately 40% year-on-year to INR 795 crores, while H1 FY27 revenue grew 39% to INR 1,551 crores. Earnings call
- EBITDA for the second quarter reached approximately INR 115 crores, up nearly 80% year-on-year, with EBITDA margin expanding by 321 basis points to 14.4%. Earnings call
- Profit after tax for Q2 FY27 increased 117% year-on-year to INR 65 crores, and H1 FY27 profit after tax doubled to INR 130 crores. Earnings call
What to watch
- Management on fy27 capex plan: We planned the capex of INR250 crores in the current year and we have already spent half of this in the first half and remaining will be spent in the second half of the year.
- Management on fy27 revenue and margin: For FY27 we perhaps will be having around 25% plus revenue growth with 14% to 15% of EBITDA generation.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.